<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00707824</url>
  </required_header>
  <id_info>
    <org_study_id>110/2000</org_study_id>
    <nct_id>NCT00707824</nct_id>
  </id_info>
  <brief_title>Epidural Nalbuphine for Postcesarean Epidural Morphine Induced Pruritus</brief_title>
  <official_title>Study of Epidural Nalbuphine for Prevention of Epidural Morphine Induced Pruritus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Can epidural nalbuphine reduce incidence or severity of epidural morphine induced pruritus in
      patient undergoing cesarean section?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      182 parturients,ASA 1-2 undergoing cesarean section under epidural block were enrolled in the
      study. After obtaining informed consent,all received epidural anesthesia using 2% lidocaine
      with epinephrine 1:200000 via epidural cathetes at L2-3 or L3-4 in a volume suffient to
      achieve a T4 sensory level bilaterally.

      After the umbilical cord was clamped,patients were assigned randomly to three groups.The
      placebo group,N-5 group,and N-10 group received 4 ml epidural solution containing morphine 4
      mg plus either saline, nalbuphine 5 mg, and nalbuphine 10 mg respectively.At the post
      anesthetic care unit, intravenous pethidine PCA were administered for inadequate pain
      control.

      Outcome measures :

      Incidence and severity of postoperative pruritus Quality of pain control Side effects of
      epidural morphine and nalbuphine such as respiratory depression,sedation
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2000</start_date>
  <completion_date type="Actual">February 2006</completion_date>
  <primary_completion_date type="Actual">December 2005</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence and severity of pruritus</measure>
    <time_frame>24 hr</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>visual analogue pain score</measure>
    <time_frame>24 hr</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">165</enrollment>
  <condition>Cesarean Section</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1= placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2=nalbuphine 5 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3=nalbuphine 10 mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nalbuphine</intervention_name>
    <description>nalbuphine 5 mg epidural</description>
    <arm_group_label>2</arm_group_label>
    <other_name>nubain</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nalbuphine</intervention_name>
    <description>nalbuphine 10 mg epidural</description>
    <arm_group_label>3</arm_group_label>
    <other_name>nubaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NSS</intervention_name>
    <description>NSS</description>
    <arm_group_label>1</arm_group_label>
    <other_name>nornal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  full term parturient undergoing elective cesarean section

          -  ASA 1-2

        Exclusion Criteria:

          -  drug or alcohol abuses

          -  contraindication for regional anesthesia

          -  received opioids within 12 hours
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Orawan Pongraweewan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mahidol University</name>
      <address>
        <city>Bangkoknoi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>February 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2008</study_first_submitted>
  <study_first_submitted_qc>June 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2008</study_first_posted>
  <last_update_submitted>July 7, 2008</last_update_submitted>
  <last_update_submitted_qc>July 7, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2008</last_update_posted>
  <responsible_party>
    <name_title>Assistant Professor Orawan Pongraweewan</name_title>
    <organization>Mahidol University</organization>
  </responsible_party>
  <keyword>pruritus</keyword>
  <keyword>epidural morphine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pruritus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Nalbuphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

